According to the results of univariate Cox regression analysis, 22 survival-related mRNAs were initially screened for the construction of the Her2-positive breast cancer risk scoring system with P < 0.01 as the critical value (Fig. 2). This evidence concerns the gene ERBB2 and breast carcinoma.